Jul 31, 202634 minS2
Aditya Juloori, MD, discusses the importance of demystifying the role of radiation oncology in lung cancer care with Aakash Desai, MD, MPH, and Fawzi F. Abu Rous, MD
health
Lung Cancer Rx
Hosted by Oncology News Central · health · EN
About this Podcast:
LungCancerRx is a new podcast that features conversations among oncologists and patients. From tackling logistical obstacles to handling existential questions, these discussions aim to provide empowerment, knowledge, and hope across the lung cancer community. Eric K. Singhi, MD, a thoracic oncologist in Houston; Aakash Desai, MD, MPH, an assistant professor at the University of Alabama Birmingham’s O’Neal Cancer Center; and Fawzi Abu Rous, MD, a thoracic medical oncologist at Henry Ford Health in Detroit, cohost each episode. “We wanted to bridge the gap between provider communication and patient communication,” explains Dr. Singhi.
Pitch Analysis
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Public web form
Booking probability
28%
Guest openness
Selective
80/100
Required Score
Sign up to generate a grounded pitch for Lung Cancer Rx.
Signup to Generate a PitchQuestions about Lung Cancer Rx
What is Lung Cancer Rx about?
LungCancerRx is a new podcast that features conversations among oncologists and patients. From tackling logistical obstacles to handling existential questions, these discussions aim to provide empowerment, knowledge, and hope across the lung cancer community. Eric K.
Who hosts Lung Cancer Rx?
Lung Cancer Rx is hosted by Oncology News Central. The show has published 14 episodes to date.
What has Lung Cancer Rx covered recently?
Recent episodes include "Why Lung Cancer Care Needs “Weed Killers” and “Crop Dusters”" (31 July 2026, 34 minutes), "More Accuracy, Less Speed? ASCO 2026 Data Further Support Targeted Therapy in Early-Stage NSCLC" (26 June 2026, 24 minutes), and "More Accuracy, Less Speed? ASCO 2026 Data Further Support Targeted Therapy in Early-Stage NSCLC" (26 June 2026, 24 minutes).
How often does Lung Cancer Rx publish?
Lung Cancer Rx publishes roughly monthly, with episodes averaging 26 minutes across 14 episodes.
How hard is it to get booked on Lung Cancer Rx?
Booking probability for Lung Cancer Rx is 28%, and the host is rated Selective on guests. Lung Cancer Rx requires a Pod Score of 80 or higher. Lung Cancer Rx's contact route on record: public web form.
Who should pitch Lung Cancer Rx?
The strongest fits for Lung Cancer Rx are Health & Wellness Services and Doctors & Physicians. Lung Cancer Rx has a health audience.
About the host
Oncology News Central hosts Lung Cancer Rx, a health podcast with 14 episodes published.
Host email not verified for this podcastSign in to unlock →
Recent episodes
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
Episode #12
More Accuracy, Less Speed? ASCO 2026 Data Further Support Targeted Therapy in Early-Stage NSCLC
Jun 26, 202624 minS0<p>Data presented at ASCO 2026 further underscore the importance of identifying which patients with early-stage NSCLC are eligible for targeted therapies. Jamie E. Chaft, MD, discusses results from the LIBRETTO, CROWN...
Episode #12
More Accuracy, Less Speed? ASCO 2026 Data Further Support Targeted Therapy in Early-Stage NSCLC
Jun 26, 202624 minData presented at ASCO 2026 further underscore the importance of identifying which patients with early-stage NSCLC are eligible for targeted therapies. Jamie E. Chaft, MD, discusses results from the LIBRETTO, CROWN, and...
- Jun 12, 202631 minS2
<p>Ferdinandos Skoulidis, MD, PhD, discusses data on KRAS- mutated NSCLC from ASCO 2026 with Aakash Desai, MD, MPH, Fawzi F. Abu Rous, MD, and Eric K. Singhi, MD.</p>
- May 1, 202629 minS0
<p>Given recent advances, where do things stand for neoadjuvant therapy in patients with NSCLC? The panel discusses current considerations and what important questions may soon be answered.</p> <p>Patrick Forde MBBCh...
View More
- Mar 13, 202631 minS0
<p>From screening to treatment, myths and misperceptions about lung cancer present challenges for physicians and patients. From setting the record straight on surgical approaches to setting higher expectations for...
- Feb 27, 202622 minS0
<p>Despite notable recent advances in lung cancer treatment, early diagnosis remains a challenge. From problems with screening criteria to changes in disease demographics, the LungCancerRx panel explains why the only...
- Dec 5, 202512 minS0
<p>To cap off the first year of the LungCancerRx podcast, cohosts Aakash Desai, MD, MPH; Eric K. Singhi, MD; and Fawzi F. Abu Rous, MD, share how they first came together and what they see as their mission for the...
- Nov 21, 202530 minS0
<p>In this episode of LungCancerRx, Eric Singhi, MD, Aakash Desai, MD, MPH, and Fawzi F. Abu Rous, MD, welcome Julia Rotow, MD to the conversation.</p> <p>“I think we’ve been very lucky, in the world of EGFR-mutated...
Episode #6
“It Unlocks This Whole World”: Better Understanding of Lung Cancer Is Generating Better Outcomes
Sep 26, 202529 minS0<p>In this episode of LungCancerRx, the experts talk about key trials presented at the World Conference on Lung Cancer, and the rapidly shifting landscape in lung cancer treatment, which now can be treated as multiple...
- Sep 12, 202526 minS0
<p>In this episode of LungCancerRx, the experts talk about the FLAURA2 and HARMONi data presented at the World Conference on Lung Cancer and what the findings mean for patients with EGFR-mutated non-small cell lung...
- Aug 22, 202531 minS0
<p>In this episode of LungCancerRx, Eric Singhi, MD, Aakash Desai, MD, MPH, and Fawzi F. Abu Rous, MD, welcome back Christine M. Lovly, MD, PhD, to talk about the complexities of treating advanced EGFR-positive NSCLC...
- Aug 8, 202529 minS0
As oncologists stand on “the cutting edge” of neoadjuvant treatment for EGFR-mutated lung cancer, how should they conduct complex conversations with patients? Christine M. Lovly, MD, PhD, joins hosts Aakash Desai, MD...
Episode #2
Empowered Choices: “The Most Important Conversations” Oncologists Can Have With NSCLC Patients
Jul 11, 202520 minS0<p>When it comes to treatment decisions for patients with EGFR-mutated non-small cell lung cancer, “the most important conversations are not the data-driven ones, they are the relational ones,” says patient advocate...
- Jun 12, 202521 minS0
<p>In the first episode of the LungCancerRx video podcast, cohosts Eric K. Singhi, MD, a thoracic oncologist in Houston; Aakash Desai, MD, MPH, an assistant professor at the University of Alabama at Birmingham’s O'Neal...
Recent guests
Recent guests on Lung Cancer Rx. Study who booked and why before you pitch.
S
Stephen Liu
Associate Professor of Medicine, Director of Thoracic Oncology, Director of Developmental Therapeutics, Lombardi Comprehensive Cancer Center of Georgetown University
E
Eric K. Singhi
Houston
A
Aakash Desai
University of Alabama at Birmingham’s O’Neal Cancer Center
P
Patrick Forde
Trinity College Dublin
Best industries to pitch Lung Cancer Rx for
PitchCentric classifies Lung Cancer Rx under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Similar Podcasts
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Podcasts like Lung Cancer Rx
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ